{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:39:18Z","timestamp":1762641558329},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/ppo.0b013e31826b124c","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T21:40:28Z","timestamp":1348263628000},"page":"457-462","source":"Crossref","is-referenced-by-count":18,"title":["Nonmyeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Issa F.","family":"Khouri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","article-title":". An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.","volume":"31","author":"Peniket","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdg200","article-title":". Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkins lymphoma.","volume":"14","author":"Hosing","year":"2003","journal-title":"Ann Oncol"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":". Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1182\/blood-2008-10-184200","article-title":". Mature results of the MD Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.","volume":"113","author":"Tam","year":"2009","journal-title":"Blood"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2005.08.012","article-title":". Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkins lymphomas.","volume":"23","author":"Khouri","year":"2005","journal-title":"J Clin Oncol"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood-2002-04-1261","article-title":". Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.","volume":"101","author":"Metayer","year":"2003","journal-title":"Blood"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbmt.2009.08.011","article-title":". A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.","volume":"16","author":"Lazarus","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1700781","article-title":". Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effects.","volume":"19","author":"Van Besien","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.bmt.1704290","article-title":". Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.","volume":"32","author":"Mandigers","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exphem.2003.09.021","article-title":". Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival.","volume":"32","author":"Khouri","year":"2004","journal-title":"Exp Hematol"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1200\/JCO.2009.26.9100","article-title":". T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma.","volume":"28","author":"Thomson","year":"2010","journal-title":"J Clin Oncol"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1182\/blood-2008-01-136242","article-title":". Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.","volume":"111","author":"Khouri","year":"2008","journal-title":"Blood"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1200\/JCO.2003.05.501","article-title":". Nonablative allogeneic stem cell transplantation for advancedrecurrent mantle cell lymphoma.","volume":"21","author":"Khouri","year":"2003","journal-title":"J Clin Oncol"},{"key":"R16-13-20210203","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":". Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkins lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"R18-13-20210203","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","article-title":". Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network.","volume":"105","author":"Dreyling","year":"2005","journal-title":"Blood"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","article-title":". Long-term progression- free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.","volume":"112","author":"Geisler","year":"2008","journal-title":"Blood"},{"key":"R20-13-20210203","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2004-06-2275","article-title":". Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.","volume":"104","author":"Maris","year":"2004","journal-title":"Blood"},{"key":"R21-13-20210203","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":". ABMT as compared with salvage chemotherapy in relapses of chemosensitive NKL.","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"R22-13-20210203","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2141.2008.07277.x","article-title":". Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.","volume":"142","author":"Alousi","year":"2008","journal-title":"Br J Haematol"},{"key":"R23-13-20210203","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/cncr.24845","article-title":". Correlation of pretransplant and early posttransplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkins lymphoma.","volume":"116","author":"Bishop","year":"2010","journal-title":"Cancer"},{"key":"R24-13-20210203","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbmt.2005.04.005","article-title":". Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-Hodgkin lymphoma.","volume":"11","author":"Dean","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R25-13-20210203","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1182\/blood-2009-11-255182","article-title":". Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma.","volume":"115","author":"Lambert","year":"2010","journal-title":"Blood"},{"key":"R26-13-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":". Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"R27-13-20210203","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":". Double-hit B-cell lymphomas.","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"R28-13-20210203","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1200\/JCO.2004.09.092","article-title":". Nonmyeloablative allogeneic haematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkins lymphoma whose disease has failed a prior autologous transplantation.","volume":"22","author":"Escalon","year":"2004","journal-title":"J Clin Oncol"},{"key":"R29-13-20210203","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1200\/JCO.2010.30.2596","article-title":". Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkins lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.","volume":"29","author":"van Kampen","year":"2011","journal-title":"J Clin Oncol"},{"key":"R30-13-20210203","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":". Peripheral t-cell lymphoma.","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"key":"R32-13-20210203","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.2009.25.8301","article-title":". Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.","volume":"28","author":"Duvic","year":"2010","journal-title":"J Clin Oncol"},{"key":"R33-13-20210203","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/annonc\/mdq698","article-title":". A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoidesSezary syndrome.","volume":"11","author":"Jacobsen","year":"2011","journal-title":"Ann Oncol"},{"key":"R35-13-20210203","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":". Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat Med"},{"key":"R36-13-20210203","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00002371-200211000-00002","article-title":"CTLA4 blockade maximizes antitumor T-cell activation by dendritic cells presenting idiotype protein or opsonized anti-CD20 antibody-coated lymphoma cells.","volume":"25","author":"Hsu","year":"2002","journal-title":"J Immunother"},{"key":"R39-13-20210203","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2007-06-097386","article-title":". High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.","volume":"110","author":"Lee","year":"2007","journal-title":"Blood"},{"key":"R40-13-20210203","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.bbmt.2010.12.702","article-title":". Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.","volume":"17","author":"Ho","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R41-13-20210203","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbmt.2008.11.013","article-title":". Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.","volume":"15","author":"Brunstein","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R42-13-20210203","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":". HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R43-13-20210203","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1200\/JCO.2010.32.1711","article-title":". Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkins lymphoma.","volume":"29","author":"Peggs","year":"2011","journal-title":"J Clin Oncol"},{"key":"R44-13-20210203","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/blood.V112.11.468.468","article-title":". First report of the prophylactic administration of ex vivo co-stimulated donor lymphocyte infusion (DLI) from related and unrelated donors after reduced intensity conditioning for high risk hematologic malignancies abstract.","volume":"112","author":"Goldstein","year":"2009","journal-title":"Blood"},{"key":"R45-13-20210203","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.bbmt.2010.12.025","article-title":". Dramatic regression of chronic lymphocytic leukemia in the first patient treated with donor derived genetically engineered anti-CD 19 chimeric antigen receptor expressing T cells after allogeneic hematopoietic stem cell transplantation.","volume":"17","author":"Kochenderfer","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R46-13-20210203","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/sj.leu.2403524","article-title":". Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation.","volume":"18","author":"Passweg","year":"2004","journal-title":"Leukemia"},{"key":"R47-13-20210203","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":". Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0b013e31826b124c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:26:45Z","timestamp":1620970005000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201209000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e31826b124c","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}